Suppr超能文献

用于栓塞治疗的载平阳霉素葡聚糖交联明胶微球的制备及其药物释放特性

Preparation and drug release characteristics of Pingyangmycin-loaded dextran cross-linked gelatin microspheres for embolization therapy.

作者信息

Wu Hong, Zhang Zhenxi, Wu Daocheng, Zhao Hongping, Yu Kaitao, Hou Zhenqing

机构信息

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, People's Republic of China.

出版信息

J Biomed Mater Res B Appl Biomater. 2006 Jul;78(1):56-62. doi: 10.1002/jbm.b.30458.

Abstract

Gelatin microspheres (GMs) containing Pingyangmycin hydrochloride were prepared for the interventional embolization by a double-phase emulsified thermal gelation method using oxidized dextran (ox-dex) as the cross-linking agent. The average diameter of the microspheres was 82 microm with 74% ranging from 50-200 microm. Drug content and the characteristics of drug release in vitro and in vivo were evaluated using UV-spectroscopy and HPLC, respectively. The prepared microspheres showed a rather high percentage of encapsulation ranging from 85 to 88% and drug content at 7.2%. The results of in vitro experiments showed that about 65.5% of the total amount of the encapsulated drug was released after 6 h at 37 degrees C. Experiments conducted through artery perfusion and artery embolization in rabbits revealed that the local drug concentration was significantly higher than the systemic blood-drug concentration, with a high level of local drug concentration maintained for more than 120 min after artery embolization with the Pingyangmycin-loaded ox-dex-GMs. The results indicated that the external carotid artery embolization with Pingyangmycin-loaded ox-dex-GMs at reduced dosages prolonged the local drug concentration at a higher level, and could achieve the purpose of a localized targeting tumor therapy. Compared with other embolization materials, ox-dex-GMs are an excellent alternative interventional embolization material for the treatment of head and neck tumors.

摘要

以氧化葡聚糖(ox-dex)为交联剂,采用双相乳化热凝胶法制备了含盐酸平阳霉素的明胶微球(GMs)用于介入栓塞。微球的平均直径为82微米,74%的微球直径在50 - 200微米之间。分别采用紫外光谱法和高效液相色谱法评估药物含量以及体外和体内的药物释放特性。制备的微球包封率相当高,在85%至88%之间,药物含量为7.2%。体外实验结果表明,在37℃下6小时后,约65.5%的包封药物总量被释放。通过对兔进行动脉灌注和动脉栓塞实验发现,局部药物浓度显著高于全身血药浓度,在用载有平阳霉素的ox-dex-GMs进行动脉栓塞后,局部药物高浓度维持超过120分钟。结果表明,用载有平阳霉素的ox-dex-GMs以降低剂量进行颈外动脉栓塞可使局部药物浓度在较高水平维持更长时间,并可实现局部靶向肿瘤治疗的目的。与其他栓塞材料相比,ox-dex-GMs是治疗头颈部肿瘤的一种优秀的替代性介入栓塞材料。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验